Correlation Between Syndax Pharmaceuticals and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Nuvalent.
Diversification Opportunities for Syndax Pharmaceuticals and Nuvalent
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Syndax and Nuvalent is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Nuvalent go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Nuvalent
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 5.99 times less return on investment than Nuvalent. In addition to that, Syndax Pharmaceuticals is 1.02 times more volatile than Nuvalent. It trades about 0.01 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.05 per unit of volatility. If you would invest 7,113 in Nuvalent on September 4, 2024 and sell it today you would earn a total of 2,314 from holding Nuvalent or generate 32.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Nuvalent
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Nuvalent |
Syndax Pharmaceuticals and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Nuvalent
The main advantage of trading using opposite Syndax Pharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |